SQZ Biotechnologies Co:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SQZ Biotechnologies Co - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10967
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SQZ Biotechnologies Co (SQZ) develops cell-based therapies that harness the body’s natural immune system against cancer. The company utilizes CellSqueeze, a technology platform for engineering various cell functions as antigen presenting cells (APCs) for immune modulation to impact oncology and autoimmune disease applications. SQZ’s APC approach enables delivery of cancer-specific antigens to the cytosol of the APC which generates polyclonal T cell responses. The company works in partnership with other academic institutions, pharmaceutical and biotechnology companies focusing on developing new cell therapies and approaches for that transform patient lives. SQZ is headquartered in Watertown, Massachusetts, the US.

SQZ Biotechnologies Co – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
SQZ Biotech Raises USD72 Million in Series C Financing 10
SQZ Biotech Raises Funds through Venture Financing 12
SQZ Biotech Raises Additional USD4 Million in Series B Financing 13
SQZ Biotech Raises USD16 Million in Series B Financing 14
SQZ Biotech Raises USD5 Million in Series A Venture Financing 15
SQZ Biotechnologies Raises Funds through Venture Financing 16
Partnerships 17
Roche Expands Agreement with SQZ Biotech 17
Licensing Agreements 18
SQZ Biotec Enters into License Agreement with Massachusetts Institute of Technology 18
SQZ Biotechnologies Co – Key Competitors 19
SQZ Biotechnologies Co – Key Employees 20
SQZ Biotechnologies Co – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Sep 27, 2018: SQZ Biotech Announces Key Executive and Board of Directors Appointments 22
Aug 23, 2017: SQZ Biotech Expands Leadership Team, Appoints Shefali Agarwal, MD, MPH, as Chief Medical Officer 23
Other Significant Developments 24
May 14, 2018: SQZ Biotech CEO to Participate in BIO International Panel and to Present at Investor Conferences in Second Quarter 2018 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Key Facts 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SQZ Biotechnologies Co, Deals By Therapy Area, 2012 to YTD 2018 8
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SQZ Biotech Raises USD72 Million in Series C Financing 10
SQZ Biotech Raises Funds through Venture Financing 12
SQZ Biotech Raises Additional USD4 Million in Series B Financing 13
SQZ Biotech Raises USD16 Million in Series B Financing 14
SQZ Biotech Raises USD5 Million in Series A Venture Financing 15
SQZ Biotechnologies Raises Funds through Venture Financing 16
Roche Expands Agreement with SQZ Biotech 17
SQZ Biotec Enters into License Agreement with Massachusetts Institute of Technology 18
SQZ Biotechnologies Co, Key Competitors 19
SQZ Biotechnologies Co, Key Employees 20

List of Figures
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SQZ Biotechnologies Co:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Immunogen, Inc.:企業の戦略・SWOT・財務分析
    Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Oiltanking GmbH-石油・ガス分野:企業M&A・提携分析
    Summary Oiltanking GmbH (Oiltanking), a subsidiary of Marquard & Bahls AG is an independent tank storage service provider. The company offers storage facilities and associated services for oils, petroleum products, chemicals, biofuels, gases and dry bulk. It owns and operates terminals in Europe, No …
  • Arab Orient Insurance Company:企業の戦略・SWOT・財務情報
    Arab Orient Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Arab Orient Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • GWA Group Limited (GWA):企業の財務・戦略的SWOT分析
    GWA Group Limited (GWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Zebra Technologies Corp (ZBRA):企業の財務・戦略的SWOT分析
    Zebra Technologies Corp (ZBRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Yue Yuen Industrial (Holdings) Limited (551):企業の財務・戦略的SWOT分析
    Yue Yuen Industrial (Holdings) Limited (551) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Antibe Therapeutics Inc (ATE)-製薬・医療分野:企業M&A・提携分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotechnology company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercialize novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen …
  • Laredo Petroleum Inc (LPI):企業の財務・戦略的SWOT分析
    Laredo Petroleum Inc (LPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Tongaat Hulett Ltd (TON):企業の財務・戦略的SWOT分析
    Tongaat Hulett Ltd (TON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Origin Energy Ltd (ORG):企業の財務・戦略的SWOT分析
    Origin Energy Ltd (ORG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Taiwan Liposome Company Ltd (4152):製薬・医療:M&Aディール及び事業提携情報
    Summary Taiwan Liposome Company Ltd (TLC) is a clinical-stage pharmaceutical company that develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of ad …
  • NMDC Ltd:企業の戦略・SWOT・財務情報
    NMDC Ltd - Strategy, SWOT and Corporate Finance Report Summary NMDC Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Mahindra Holidays & Resorts India Limited:企業の戦略・SWOT・財務分析
    Mahindra Holidays & Resorts India Limited - Strategy, SWOT and Corporate Finance Report Summary Mahindra Holidays & Resorts India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • GTx Inc (GTXI):製薬・医療:M&Aディール及び事業提携情報
    Summary GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers including breast and prostate cancer; and other serious medical condition …
  • Dermira Inc (DERM)-医療機器分野:企業M&A・提携分析
    Summary Dermira Inc (Dermira) is a bio-pharmaceutical company which concentrates on the development and commercialization of novel therapies for the treatment of chronic skin conditions. The company concentrates on developing drugs for the treatment of diseases such as psoriasis, hyperhidrosis, atop …
  • Oranje-Nassau Energie BV:石油・ガス:M&Aディール及び事業提携情報
    Summary Oranje-Nassau Energie BV (ONE) is an upstream oil and gas company which focuses on the exploration and production of oil and natural gas. It concentrates on exploration assets in the southern North Sea Ventures such as the Netherlands and the UK. It also has assets in Kowe Block and Agali Bl …
  • Cytox Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict …
  • Internet Initiative Japan Inc (3774):企業の財務・戦略的SWOT分析
    Internet Initiative Japan Inc (3774) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Marui Group Co., Ltd.:企業の戦略・SWOT・財務情報
    Marui Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Marui Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MEI Pharma Inc (MEIP):企業の財務・戦略的SWOT分析
    MEI Pharma Inc (MEIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆